AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22905926 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonalbuminuric RI
Number of subjects: 2642
Study 20484058 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally relevant group diabetes self‐management training (DSMT), coping skills training (CST), and diabetes care intervention
Number of subjects: 109
Study 20484058 — intervention group
Group type: COMPARATOR
Intervention: Usual diabetes education and diabetes care intervention
Number of subjects: 109
Study 18029924 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath holding at inspiration
Number of subjects: 23
Study 18029924 — intervention group
Group type: COMPARATOR
Intervention: Free breathing
Number of subjects: 23
Study 18029924 — intervention group
Group type: COMPARATOR
Intervention: Breath holding at expiration
Number of subjects: 23
Study 18029924 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy subjects during breath holding at inspiration
Number of subjects: 23
Study 15809933 — intervention group
Group type: EXPERIMENTAL
Intervention: TARGeted Intraoperative radiotherapy (TARGIT)
Number of subjects: 0
Study 15809933 — intervention group
Group type: COMPARATOR
Intervention: Conventional postoperative radiotherapy
Number of subjects: 0
Study 12383160 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialized heart failure disease-management programs
Number of subjects: 1937
Study 12383160 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialized follow-up by multidisciplinary teams
Number of subjects: 1937
Study 12383160 — intervention group
Group type: COMPARATOR
Intervention: Follow-up by primary care physicians and telephone
Number of subjects: 1937
Study 12383160 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialized disease-management programs
Number of subjects: 1937
Study 12383160 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life or functional status
Number of subjects: 1937
Study 12383160 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost analyses
Number of subjects: 1937
Study 10447991 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of emphasis in narratives
Number of subjects: 0
Study 10447991 — intervention group
Group type: EXPERIMENTAL
Intervention: Low linguistic complexity condition
Number of subjects: 0
Study 10447991 — intervention group
Group type: EXPERIMENTAL
Intervention: High linguistic complexity condition
Number of subjects: 0
Study 7598669 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) - 10-session treatment package including progressive relaxation, rational thinking, and pain coping strategies.
Number of subjects: 3
Study 7598669 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational Therapy (OT)
Number of subjects: 3
Study 7598669 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 3
Study 2358617 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg Zn daily for 12 months
Number of subjects: 0
Study 2358617 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg Zn daily for 12 months
Number of subjects: 0
Study 2358617 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 475632 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic saline drops every three hours for one week
Number of subjects: 20
Study 475632 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline drops
Number of subjects: 20
Study 475632 — intervention group
Group type: COMPARATOR
Intervention: One-half isotonic saline solution
Number of subjects: 20
Study 475632 — intervention group
Group type: EXPERIMENTAL
Intervention: Tear film osmolarity
Number of subjects: 20
Study 30944054 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-based monitoring
Number of subjects: 129
Study 30944054 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 129
Study 31128251 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative (1 month after operation)
Number of subjects: 9
Study 31128251 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative (2 months after operation)
Number of subjects: 9
Study 31128251 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative (3 months after operation)
Number of subjects: 9
Study 28616923 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 0.5 mg/kg (TRM1)
Number of subjects: 120
Study 28616923 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 1 mg/kg (TRM2)
Number of subjects: 120
Study 28616923 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 1.5 mg/kg (TRM3)
Number of subjects: 120
Study 28616923 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Control group)
Number of subjects: 120
Study 25825006 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based monthly monitoring with the Childhood Asthma Control Test (ACT)
Number of subjects: 280
Study 25825006 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-monthly monitoring of FENO
Number of subjects: 280
Study 25825006 — intervention group
Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 280
Study 25825006 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based ACT monitoring
Number of subjects: 280
Study 24068825 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine 150 mg XL for 7 days
Number of subjects: 20
Study 24068825 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 21586690 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP‐1(7‐36) amide at 1.2 pmol/kg per minute
Number of subjects: 20
Study 21586690 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 20
Study 19447598 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-shot spinal
Number of subjects: 60
Study 19447598 — intervention group
Group type: COMPARATOR
Intervention: Combined spinal-epidural
Number of subjects: 60
Study 19447598 — intervention group
Group type: COMPARATOR
Intervention: Epidural volume extension of a combined spinal-epidural
Number of subjects: 60
Study 16597716 — intervention group
Group type: EXPERIMENTAL
Intervention: fMRI response to local contrast
Number of subjects: 0
Study 16597716 — intervention group
Group type: EXPERIMENTAL
Intervention: Modulating a surrounding field
Number of subjects: 0
Study 16597716 — intervention group
Group type: EXPERIMENTAL
Intervention: Modeling fMRI responses
Number of subjects: 0
Study 16597716 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurons identified in neurophysiological studies
Number of subjects: 0
Study 16597716 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual field maps of human V1 and V2
Number of subjects: 0
Study 12699266 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical ablation or resection
Number of subjects: 0
Study 12699266 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled ovarian hyperstimulation techniques with intrauterine inseminations
Number of subjects: 0
Study 12699266 — intervention group
Group type: EXPERIMENTAL
Intervention: IVF (In Vitro Fertilization)
Number of subjects: 0
Study 12699266 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretreatment with GnRH agonists before IVF cycle initiation
Number of subjects: 0
Study 11092289 — intervention group
Group type: EXPERIMENTAL
Intervention: Nateglinide 120 mg before meals
Number of subjects: 701
Study 11092289 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 500 mg three times a day
Number of subjects: 701
Study 11092289 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (nateglinide + metformin)
Number of subjects: 701
Study 11092289 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 701
Study 9170525 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous bolus injection of 5 mg azasetron before and 8 hours after chemotherapy
Number of subjects: 0
Study 9170525 — intervention group
Group type: COMPARATOR
Intervention: Standard group receiving intravenous bolus injection of 10 mg azasetron once a day
Number of subjects: 0
Study 15374310 — intervention group
Group type: EXPERIMENTAL
Intervention: Single visit from health visitor at 72 hours
Number of subjects: 204
Study 15374310 — intervention group
Group type: COMPARATOR
Intervention: Normal follow-up services (Control)
Number of subjects: 204
Study 2971310 — intervention group
Group type: EXPERIMENTAL
Intervention: Celiprolol (400 mg once a day)
Number of subjects: 20
Study 2971310 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 30313092 — intervention group
Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia (TIVA) (propofol and remifentanil)
Number of subjects: 56
Study 30313092 — intervention group
Group type: COMPARATOR
Intervention: Desflurane anesthesia (DES) (desflurane and remifentanil)
Number of subjects: 56
Study 25913923 — intervention group
Group type: EXPERIMENTAL
Intervention: IR/ER HB/APAP (7.5/325 mg) fixed-dose combination analgesic agent, initial dose of 22.5/975 mg on day 1, followed by 15/650 mg every 12 hours for up to 35 days.
Number of subjects: 153
Study 25913923 — intervention group
Group type: EXPERIMENTAL
Intervention: IR/ER HB/APAP (7.5/325 mg) fixed-dose combination analgesic agent.
Number of subjects: 153
Study 24469870 — intervention group
Group type: EXPERIMENTAL
Intervention: N-3 polyunsaturated fatty acids (Omacor) 1 g daily
Number of subjects: 40
Study 24469870 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard therapy + 75 mg acetylsalicylic acid + 75 mg clopidogrel)
Number of subjects: 40
Study 20861530 — intervention group
Group type: EXPERIMENTAL
Intervention: Energicer (COOL)
Number of subjects: 18
Study 20861530 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 18
Study 19048591 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids alone
Number of subjects: 253
Study 19048591 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids and azathioprine
Number of subjects: 253
Study 19048591 — intervention group
Group type: COMPARATOR
Intervention: ACE inhibitors alone or associated with corticosteroids
Number of subjects: 253
Study 15857350 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboxymethylcellulose (CMC)
Number of subjects: 70
Study 15857350 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 12643610 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole
Number of subjects: 21
Study 10917259 — intervention group
Group type: EXPERIMENTAL
Intervention: Molded ankle-foot orthosis (MAFO)
Number of subjects: 4
Study 8945863 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepwise linear discriminant analysis applied to electromyographic interference patterns
Number of subjects: 186
Study 1959498 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetrabamate (900 mg/day)
Number of subjects: 269
Study 1959498 — intervention group
Group type: COMPARATOR
Intervention: Lorazepam (4.5 mg/day)
Number of subjects: 269
Study 1959498 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 269
Study 1959498 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetrabamate
Number of subjects: 269
Study 6753119 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirenzepine (100 mg/daily)
Number of subjects: 50
Study 6753119 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 31419809 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined resistance training with sport-specific drill (CRT)
Number of subjects: 22
Study 31419809 — intervention group
Group type: COMPARATOR
Intervention: Resistance training without any sport-specific drill training (NSDT)
Number of subjects: 22
Study 28713109 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% neem mouthwash
Number of subjects: 40
Study 28713109 — intervention group
Group type: COMPARATOR
Intervention: 0.2% chlorhexidine gluconate
Number of subjects: 40
Study 25855267 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release carbidopa-levodopa (ER CD-LD) 97.5 mg-390 mg
Number of subjects: 0
Study 25855267 — intervention group
Group type: COMPARATOR
Intervention: Immediate-release carbidopa-levodopa (IR CD-LD) 25 mg-100 mg
Number of subjects: 0
Study 25855267 — intervention group
Group type: COMPARATOR
Intervention: Sustained-release carbidopa-levodopa (CR CD-LD) 25 mg-100 mg
Number of subjects: 0
Study 25855267 — intervention group
Group type: COMPARATOR
Intervention: Carbidopa-levodopa-entacapone (Stalevo) 25 mg-100 mg-200 mg
Number of subjects: 0
Study 23942038 — intervention group
Group type: EXPERIMENTAL
Intervention: Double dose of levocetirizine
Number of subjects: 0
Study 23942038 — intervention group
Group type: COMPARATOR
Intervention: Conventional dose of levocetirizine
Number of subjects: 0
Study 21286837 — intervention group
Group type: EXPERIMENTAL
Intervention: Revised consent laws for HIV testing
Number of subjects: 53036383
Study 21286837 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased diagnosis rate (24.8-72.3%)
Number of subjects: 53036383
Study 21286837 — intervention group
Group type: EXPERIMENTAL
Intervention: Proportion of HIV-infected persons refusing testing exceeds 18.2%
Number of subjects: 53036383
Study 19675538 — intervention group
Group type: EXPERIMENTAL
Intervention: Catecholamine depletion (CD) achieved by oral administration of alpha‐methyl‐paratyrosine (AMPT)
Number of subjects: 27
Study 19675538 — intervention group
Group type: COMPARATOR
Intervention: Healthy female controls
Number of subjects: 27
Study 19675538 — intervention group
Group type: EXPERIMENTAL
Intervention: Affective Stroop task
Number of subjects: 27
Study 17877165 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A + C meningococcal polysaccharide vaccine (100 microg)
Number of subjects: 428
Study 17877165 — intervention group
Group type: COMPARATOR
Intervention: Group A meningococcal polysaccharide vaccine (50 microg)
Number of subjects: 428
Study 17877165 — intervention group
Group type: COMPARATOR
Intervention: Typhoid Vi polysaccharide vaccine (30 microg)
Number of subjects: 428
Study 15190797 — intervention group
Group type: EXPERIMENTAL
Intervention: PDLLA biomembrane
Number of subjects: 68
Study 15190797 — intervention group
Group type: COMPARATOR
Intervention: Traditional surgical method
Number of subjects: 68
Study 11550752 — intervention group
Group type: EXPERIMENTAL
Intervention: Delay making the decision (Experiment 1)
Number of subjects: 0
Study 11550752 — intervention group
Group type: EXPERIMENTAL
Intervention: Memorize the case (Experiment 2)
Number of subjects: 0
Study 11550752 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehend the case (Experiment 3)
Number of subjects: 0
Study 9778712 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% hydroxyethyl starch
Number of subjects: 36
Study 9778712 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% gelatin
Number of subjects: 36
Study 9778712 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% human albumin
Number of subjects: 36
Study 8012622 — intervention group
Group type: EXPERIMENTAL
Intervention: Formal training in smoking cessation
Number of subjects: 30
Study 8012622 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention with smokers
Number of subjects: 30
Study 8012622 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoke-free policies
Number of subjects: 30
Study 8012622 — intervention group
Group type: EXPERIMENTAL
Intervention: Printed materials on smoking cessation
Number of subjects: 30
Study 8012622 — intervention group
Group type: EXPERIMENTAL
Intervention: Staff coordination for smoking cessation activities
Number of subjects: 30
Study 2902263 — intervention group
Group type: EXPERIMENTAL
Intervention: Edmonston-Zagreb (EZ) measles vaccine, 40,000 plaque forming units
Number of subjects: 558
Study 2902263 — intervention group
Group type: COMPARATOR
Intervention: Schwarz measles vaccine, 6000 tissue culture infectious units
Number of subjects: 558
Study 2902263 — intervention group
Group type: EXPERIMENTAL
Intervention: Edmonston-Zagreb (EZ) measles vaccine
Number of subjects: 558
Study 31204129 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose Custodiol histidine‐tryptophan‐ketoglutarate
Number of subjects: 110
Study 31204129 — intervention group
Group type: COMPARATOR
Intervention: Repetitive cold‐blood cardioplegia
Number of subjects: 110
Study 31634179 — intervention group
Group type: EXPERIMENTAL
Intervention: Near-total thyroidectomy (NTT)
Number of subjects: 205
Study 31634179 — intervention group
Group type: COMPARATOR
Intervention: Total thyroidectomy (TT)
Number of subjects: 205
Study 28256384 — intervention group
Group type: EXPERIMENTAL
Intervention: Headless, cannulated Herbert screws
Number of subjects: 40
Study 28256384 — intervention group
Group type: COMPARATOR
Intervention: Conventional locking plate system
Number of subjects: 40
Study 25421802 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity patient simulation (HFPS)
Number of subjects: 55
Study 25421802 — intervention group
Group type: COMPARATOR
Intervention: Control group (no HFPS)
Number of subjects: 55
Study 23586936 — intervention group
Group type: EXPERIMENTAL
Intervention: Lawsone methyl ether (LME) mouthwash
Number of subjects: 67
Study 23586936 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine (CHX) mouthwash
Number of subjects: 67
Study 21592508 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc plus placebo vitamin A (group 1)
Number of subjects: 167
Study 21592508 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc plus other micronutrients plus vitamin A (group 2)
Number of subjects: 167
Study 21592508 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc plus vitamin A (group 3)
Number of subjects: 167
Study 21592508 — intervention group
Group type: COMPARATOR
Intervention: Placebo (group 4)
Number of subjects: 167
Study 18665763 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser, 250 mJ, at 2 Hz
Number of subjects: 12
Study 18665763 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser, 250 mJ, at 3 Hz
Number of subjects: 12
Study 18665763 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser, 250 mJ, at 4 Hz
Number of subjects: 12
Study 18665763 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser, 350 mJ, at 2 Hz
Number of subjects: 12
Study 18665763 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser, 350 mJ, at 3 Hz
Number of subjects: 12
Study 18665763 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser, 350 mJ, at 4 Hz
Number of subjects: 12
Study 18665763 — intervention group
Group type: COMPARATOR
Intervention: High-speed handpiece (control)
Number of subjects: 12
Study 16446183 — intervention group
Group type: EXPERIMENTAL
Intervention: Fondaparinux administered 8 +/- 2 hours after surgery
Number of subjects: 0
Study 16446183 — intervention group
Group type: EXPERIMENTAL
Intervention: Fondaparinux administered the morning after surgery
Number of subjects: 0
Study 12946548 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 12 microg BID via single-dose dry powder inhaler plus on‐demand salbutamol
Number of subjects: 6155
Study 12946548 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol plus on‐demand salbutamol
Number of subjects: 6155
Study 12946548 — intervention group
Group type: COMPARATOR
Intervention: On-demand salbutamol alone or salmeterol 50 microg BID via multidose dry powder inhaler plus on‐demand salbutamol
Number of subjects: 6155
Study 11194599 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mmol intravenous magnesium
Number of subjects: 36
Study 11194599 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mmol intravenous magnesium
Number of subjects: 36
Study 11194599 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mmol intravenous magnesium
Number of subjects: 36
Study 11194599 — intervention group
Group type: COMPARATOR
Intervention: 0 mmol intravenous magnesium (placebo)
Number of subjects: 36
Study 9375333 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% O2
Number of subjects: 34
Study 9375333 — intervention group
Group type: COMPARATOR
Intervention: Room air (RA)
Number of subjects: 34
Study 1488561 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 micrograms formoterol
Number of subjects: 12
Study 1488561 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 micrograms salbutamol
Number of subjects: 12
Study 1488561 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 2999455 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose oral acyclovir
Number of subjects: 40
Study 2999455 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 2999455 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir
Number of subjects: 40
Study 31628723 — intervention group
Group type: EXPERIMENTAL
Intervention: Online automated pain coping skills training program (PCST) for 8 weeks
Number of subjects: 12
Study 31628723 — intervention group
Group type: EXPERIMENTAL
Intervention: Online automated pain coping skills training program (PCST)
Number of subjects: 12
Study 29658344 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives (OCP)
Number of subjects: 90
Study 29658344 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (M) + Oral contraceptives (OCP)
Number of subjects: 90
Study 29658344 — intervention group
Group type: COMPARATOR
Intervention: Metformin (M)
Number of subjects: 90
Study 29658344 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooled data (M, OCP, M + OCP)
Number of subjects: 90
Study 27982406 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytotherapy (Gan Mai Da Zao formula, 50 ml)
Number of subjects: 89
Study 27982406 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 89
Study 27982406 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study 24572995 — intervention group
Group type: EXPERIMENTAL
Intervention: Prilocaine-lidocaine (PLA) cream applied to the glans penis for 10 min before measurements
Number of subjects: 60
Study 24572995 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream applied to the glans penis for 10 min before measurements
Number of subjects: 60
Study 22498045 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral nerve block
Number of subjects: 40
Study 22498045 — intervention group
Group type: COMPARATOR
Intervention: Morphine (routine intravenous narcotics)
Number of subjects: 40
Study 20430594 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Lithium levels (<0.6 mmol/L)
Number of subjects: 0
Study 20430594 — intervention group
Group type: COMPARATOR
Intervention: Medium Lithium levels (0.6-0.79 mmol/L)
Number of subjects: 0
Study 20430594 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Olanzapine doses (<10mg/day)
Number of subjects: 0
Study 20430594 — intervention group
Group type: COMPARATOR
Intervention: Higher Olanzapine doses (10-20mg/day)
Number of subjects: 0
Study 17269594 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxacalcitol
Number of subjects: 31